Aeson® is an active implantable medical device intended to replace the ventricles of the native heart in patients suffering from advanced heart failure. The device is electro-hydraulically …

Dec 11, 2023 · The world’s first physiological artificial heart that is highly hemocompatible, pulsatile and self-regulated, Aeson® could save, every year, the lives of thousands of patients …

The implantation technique for the Aeson Total Artificial Heart, indicated to replace both ventricles, is described in detail aiming to ensure surgical safety for optimal patient outcomes.

Feb 10, 2025 · CARMAT (FR0010907956, ALCAR), the developer of the world’s most advanced total artificial heart, has achieved a significant milestone with the successful implantation of …

The autoregulated, pulsatile Aeson total artificial heart (Carmat SA, Velizy, France) is a sin-gle-unit biventricular device.

Aeson ® is a Total Artificial Heart. Unlike other mechanical circulatory support devices, such as LVAD (left ventricular assist devices) that assist the left ventricle of the heart, Aeson® Total …

Mar 1, 2023 · The Aeson (CARMAT SA) is the newest generation total artificial heart (TAH) that provides right- and left-sided heart replacement. This report describes the first clinical …

Nov 13, 2024 · CARMAT (FR0010907956, ALCAR), designer and developer of the world’s most advanced total artificial heart, aiming to provide a therapeutic alternative for people suffering …

Feb 17, 2025 · The Aeson® total artificial heart is intended to replace the ventricles of the native heart and is indicated as a bridge to transplant in patients with end-stage biventricular heart …

The Aeson total artificial heart provides biventricular support with improvements in hemocompatibility and autoregulation in response to higher filling pressures, when compared …